Stockscreener 앱 받기
25.86
0.58%
-0.15
전일 마감가:
$26.01
열려 있는:
$26.01
하루 거래량:
395.48K
Relative Volume:
0.67
시가총액:
$1.22B
수익:
$723.55M
순이익/손실:
$157.72M
주가수익비율:
8.62
EPS:
3
순현금흐름:
$170.15M
1주 성능:
+2.38%
1개월 성능:
+5.55%
6개월 성능:
-41.63%
1년 성능:
-38.75%
1일 변동 폭
$25.75
$26.57
1주일 범위
$25.13
$26.57
52주 변동 폭
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.86 | 1.19B | 723.55M | 157.72M | 170.15M | 3.00 |
|
HLN
Haleon Plc Adr
|
10.93 | 50.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.59 | 73.64B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.92 | 4.12M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.57B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.52 | 20.82B | 16.54B | -1.64B | 749.00M | -1.45 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com
Amphastar Pharmaceuticals Stockholders Approve Key Amendments - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in May - Defense World
Squarepoint Ops LLC Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Significant Growth in Short Interest - MarketBeat
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Nuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar price target lowered to $35 from $40 at Wells Fargo - MSN
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Man Group plc Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Voloridge Investment Management LLC - MarketBeat
Deutsche Bank AG Buys 10,839 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 792 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Deutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Twinbeech Capital LP Invests $1.74 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Ameriprise Financial Inc. Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by BNP Paribas Financial Markets - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Janus Henderson Group PLC - MarketBeat
246,348 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Acquired by Systematic Financial Management LP - MarketBeat
D. E. Shaw & Co. Inc. Boosts Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers - FinancialContent
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - ACCESS Newswire
Amphastar CFO to Lead Fireside Chat at Jefferies Global Healthcare Conference June 5 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Northern Trust Corp Acquires 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Jane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals' (AMPH) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
Comerica Bank Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given “Neutral” Rating at JPMorgan Chase & Co. - Defense World
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45 - marketscreener.com
Amphastar (AMPH) Faces Downgrade Amid Pipeline Challenges | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals, Comstock, Range Resources - TradingView
Amphastar Pharmaceuticals: Navigating Through An Inflection Year (NASDAQ:AMPH) - Seeking Alpha
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Wells Fargo & Company Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $35.00 - Defense World
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.61%
자본화:
|
볼륨(24시간):